Clinical Trial Update: A Study to Evaluate the Safety and Tolerability of RO7296682 in Participants With Advanced Solid Tumors [Phase 1]

View source ↗

Summary

Phase 1 trial evaluating safety and tolerability of RO7296682 in participants with advanced solid tumors; study terminated with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Solid Tumor

Drugs mentioned

• RO7296682

Snippet

Sponsor: Hoffmann-La Roche | Conditions: Solid Tumors | Phase 1 | Status: TERMINATED | Results posted: 2024-03-04